In agreement with the proposed central role of the aberrant splicing in tumorigenesis, the altered splicing of FGFR2 and the consequent appearance of the mesenchymal FGFR2c isoform was observed in several carcinomas [40,41,42,43,44]. This evidence concerns the gene FGFR2 and carcinoma.